• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Induction of complement C3a receptor responses by kallikrein-related peptidase 14.激肽释放酶相关肽酶 14 诱导补体 C3a 受体反应。
J Immunol. 2013 Oct 1;191(7):3858-66. doi: 10.4049/jimmunol.1202999. Epub 2013 Sep 6.
2
Activation of C3a receptor is required in cigarette smoke-mediated emphysema.香烟烟雾介导的肺气肿需要C3a受体的激活。
Mucosal Immunol. 2015 Jul;8(4):874-85. doi: 10.1038/mi.2014.118. Epub 2014 Dec 3.
3
C3 Drives Inflammatory Skin Carcinogenesis Independently of C5.C3 独立于 C5 驱动炎症性皮肤癌发生。
J Invest Dermatol. 2021 Feb;141(2):404-414.e6. doi: 10.1016/j.jid.2020.06.025. Epub 2020 Jul 16.
4
Complement component C3 is required for protective innate and adaptive immunity to larval strongyloides stercoralis in mice.补体成分C3是小鼠对幼虫期粪类圆线虫产生保护性固有免疫和适应性免疫所必需的。
J Immunol. 2006 Apr 1;176(7):4315-22. doi: 10.4049/jimmunol.176.7.4315.
5
A new role of the complement system: C3 provides protection in a mouse model of lung infection with intracellular Chlamydia psittaci.补体系统的新作用:C3 在小鼠细胞内鹦鹉热衣原体肺部感染模型中提供保护。
PLoS One. 2012;7(11):e50327. doi: 10.1371/journal.pone.0050327. Epub 2012 Nov 26.
6
Autoantibody-mediated arthritis in the absence of C3 and activating Fcγ receptors: C5 is activated by the coagulation cascade.在缺乏C3和激活型Fcγ受体的情况下,自身抗体介导的关节炎:凝血级联反应激活C5。
Arthritis Res Ther. 2012 Dec 13;14(6):R269. doi: 10.1186/ar4117.
7
Polyglycolic acid-induced inflammation: role of hydrolysis and resulting complement activation.聚乙醇酸诱导的炎症:水解作用及由此导致的补体激活的作用
Tissue Eng. 2006 Feb;12(2):301-8. doi: 10.1089/ten.2006.12.301.
8
Activation of complement components C3 and C5 by a cysteine proteinase (gingipain-1) from Porphyromonas (Bacteroides) gingivalis.牙龈卟啉单胞菌(拟杆菌属)的一种半胱氨酸蛋白酶(牙龈蛋白酶-1)对补体成分C3和C5的激活作用。
J Biol Chem. 1992 Sep 15;267(26):18902-7.
9
The secreted Candida albicans protein Pra1 disrupts host defense by broadly targeting and blocking complement C3 and C3 activation fragments.白色念珠菌分泌的蛋白Pra1通过广泛靶向并阻断补体C3及其激活片段来破坏宿主防御。
Mol Immunol. 2018 Jan;93:266-277. doi: 10.1016/j.molimm.2017.07.010. Epub 2017 Aug 30.
10
Complement and : Early Complement-Dependent Events Are Important for DC Migration and Protection During Mouse Lung Infection.补体系统和:早期补体依赖性事件对小鼠肺部感染期间 DC 的迁移和保护很重要。
Front Immunol. 2021 Mar 9;12:580594. doi: 10.3389/fimmu.2021.580594. eCollection 2021.

引用本文的文献

1
Comparative analyses of Netherton syndrome patients and Spink5 conditional knock-out mice uncover disease-relevant pathways.Netherton综合征患者与Spink5条件性基因敲除小鼠的比较分析揭示了疾病相关途径。
Commun Biol. 2024 Feb 5;7(1):152. doi: 10.1038/s42003-024-05780-y.
2
The innate immune response, microenvironment proteinases, and the COVID-19 pandemic: pathophysiologic mechanisms and emerging therapeutic targets.先天性免疫反应、微环境蛋白酶与COVID-19大流行:病理生理机制及新出现的治疗靶点
Kidney Int Suppl (2011). 2022 Apr;12(1):48-62. doi: 10.1016/j.kisu.2021.12.001. Epub 2022 Mar 18.
3
Remodelling of the tumour microenvironment by the kallikrein-related peptidases.激肽释放酶相关肽酶重塑肿瘤微环境。
Nat Rev Cancer. 2022 Apr;22(4):223-238. doi: 10.1038/s41568-021-00436-z. Epub 2022 Jan 31.
4
Crosstalk between the renin-angiotensin, complement and kallikrein-kinin systems in inflammation.肾素-血管紧张素、补体和激肽释放酶-激肽系统在炎症中的相互作用。
Nat Rev Immunol. 2022 Jul;22(7):411-428. doi: 10.1038/s41577-021-00634-8. Epub 2021 Nov 10.
5
Angiotensin-converting enzyme 2, the complement system, the kallikrein-kinin system, type-2 diabetes, interleukin-6, and their interactions regarding the complex COVID-19 pathophysiological crossroads.血管紧张素转换酶 2、补体系统、激肽释放酶-激肽系统、2 型糖尿病、白细胞介素 6 及其相互作用在复杂的 COVID-19 病理生理学交汇点。
J Renin Angiotensin Aldosterone Syst. 2020 Oct-Dec;21(4):1470320320979097. doi: 10.1177/1470320320979097.
6
Kallikrein 5 overexpression is associated with poor prognosis in uterine cervical cancer.激肽释放酶 5 的过表达与宫颈癌的预后不良有关。
J Gynecol Oncol. 2020 Nov;31(6):e78. doi: 10.3802/jgo.2020.31.e78.
7
Proteinases and their receptors in inflammatory arthritis: an overview.炎症性关节炎中的蛋白酶及其受体:概述。
Nat Rev Rheumatol. 2018 Mar;14(3):170-180. doi: 10.1038/nrrheum.2018.17. Epub 2018 Feb 8.
8
Auxiliary activation of the complement system and its importance for the pathophysiology of clinical conditions.补体系统的辅助激活及其在临床状况病理生理学中的重要性。
Semin Immunopathol. 2018 Jan;40(1):87-102. doi: 10.1007/s00281-017-0646-9. Epub 2017 Sep 12.
9
Complement component C3 - The "Swiss Army Knife" of innate immunity and host defense.补体成分C3——固有免疫和宿主防御的“瑞士军刀”。
Immunol Rev. 2016 Nov;274(1):33-58. doi: 10.1111/imr.12500.
10
Differential expression of multiple kallikreins in a viral model of multiple sclerosis points to unique roles in the innate and adaptive immune response.多种激肽释放酶在多发性硬化症病毒模型中的差异表达表明其在先天性和适应性免疫反应中具有独特作用。
Biol Chem. 2014 Sep;395(9):1063-73. doi: 10.1515/hsz-2014-0141.

本文引用的文献

1
Complement in immune and inflammatory disorders: pathophysiological mechanisms.补体在免疫和炎症性疾病中的作用:病理生理机制。
J Immunol. 2013 Apr 15;190(8):3831-8. doi: 10.4049/jimmunol.1203487.
2
International Union of Basic and Clinical Pharmacology. [corrected]. LXXXVII. Complement peptide C5a, C4a, and C3a receptors.国际基础和临床药理学联合会。[更正]。LXXXVII. 补体肽 C5a、C4a 和 C3a 受体。
Pharmacol Rev. 2013 Jan;65(1):500-43. doi: 10.1124/pr.111.005223.
3
C5a receptor-dependent cell activation by physiological concentrations of desarginated C5a: insights from a novel label-free cellular assay.生理浓度的去精氨酸 C5a 通过 C5a 受体依赖性细胞激活:来自新型无标记细胞检测的见解。
J Immunol. 2012 Nov 15;189(10):4797-805. doi: 10.4049/jimmunol.1200834. Epub 2012 Oct 5.
4
Thrombin generates previously unidentified C5 products that support the terminal complement activation pathway.凝血酶生成了先前未被识别的 C5 产物,这些产物支持末端补体激活途径。
Blood. 2012 Aug 23;120(8):1717-25. doi: 10.1182/blood-2012-02-412080. Epub 2012 Jul 16.
5
Targeting proteinase-activated receptors: therapeutic potential and challenges.靶向蛋白酶激活受体:治疗潜力与挑战。
Nat Rev Drug Discov. 2012 Jan 3;11(1):69-86. doi: 10.1038/nrd3615.
6
Kallikrein-related peptidase 14 acts on proteinase-activated receptor 2 to induce signaling pathway in colon cancer cells.激肽释放酶相关肽酶 14 通过作用于蛋白酶激活受体 2 诱导结肠癌细胞中的信号通路。
Am J Pathol. 2011 Nov;179(5):2625-36. doi: 10.1016/j.ajpath.2011.07.016. Epub 2011 Sep 9.
7
Complement in skin diseases.皮肤疾病中的补体
Acta Dermatovenerol Alp Pannonica Adriat. 2011;20(1):3-11.
8
Interactions between coagulation and complement--their role in inflammation.凝血与补体之间的相互作用——它们在炎症中的作用。
Semin Immunopathol. 2012 Jan;34(1):151-65. doi: 10.1007/s00281-011-0280-x. Epub 2011 Aug 3.
9
Label-free cell-based assays using photonic crystal optical biosensors.基于光子晶体光学生物传感器的无标记细胞分析。
Analyst. 2011 Mar 21;136(6):1090-102. doi: 10.1039/c0an00899k. Epub 2011 Jan 28.
10
Molecular intercommunication between the complement and coagulation systems.补体系统与凝血系统的分子相互通讯。
J Immunol. 2010 Nov 1;185(9):5628-36. doi: 10.4049/jimmunol.0903678. Epub 2010 Sep 24.

激肽释放酶相关肽酶 14 诱导补体 C3a 受体反应。

Induction of complement C3a receptor responses by kallikrein-related peptidase 14.

机构信息

Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104;

出版信息

J Immunol. 2013 Oct 1;191(7):3858-66. doi: 10.4049/jimmunol.1202999. Epub 2013 Sep 6.

DOI:10.4049/jimmunol.1202999
PMID:24014879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3922206/
Abstract

Activation of the complement system is primarily initiated by pathogen- and damage-associated molecular patterns on cellular surfaces. However, there is increasing evidence for direct activation of individual complement components by extrinsic proteinases as part of an intricate crosstalk between physiological effector systems. We hypothesized that kallikrein-related peptidases (KLKs), previously known to regulate inflammation via proteinase-activated receptors, can also play a substantial role in innate immune responses via complement. Indeed, KLKs exemplified by KLK14 were efficiently able to cleave C3, the point of convergence of the complement cascade, indicating a potential modulation of C3-mediated functions. By using in vitro fragmentation assays, mass spectrometric analysis, and cell signaling measurements, we pinpointed the generation of the C3a fragment of C3 as a product with potential biological activity released by the proteolytic action of KLK14. Using mice with various complement deficiencies, we demonstrated that the intraplantar administration of KLK14 results in C3-associated paw edema. The edema response was dependent on the presence of the receptor for C3a but was not associated with the receptor for the downstream complement effector C5a. Our findings point to C3 as one of the potential substrates of KLKs during inflammation. Given the wide distribution of the KLKs in tissues and biological fluids where complement components may also be expressed, we suggest that via C3 processing, tissue-localized KLKs can play an extrinsic complement-related role during activation of the innate immune response.

摘要

补体系统的激活主要由细胞表面的病原体和损伤相关的分子模式引发。然而,越来越多的证据表明,某些补体成分可被外在蛋白水解酶直接激活,这是生理效应系统之间复杂串扰的一部分。我们假设,先前已知通过蛋白酶激活受体来调节炎症的激肽释放酶相关肽酶(KLKs)也可以通过补体在先天免疫反应中发挥重要作用。事实上,以 KLK14 为例的 KLKs 能够有效地切割 C3,即补体级联反应的汇聚点,表明 C3 介导的功能可能受到调节。通过使用体外片段化测定、质谱分析和细胞信号测量,我们确定 C3 的 C3a 片段的产生是 KLK14 的蛋白水解作用释放的具有潜在生物学活性的产物。使用具有各种补体缺陷的小鼠,我们证明 KLK14 的皮内给药会导致 C3 相关的爪肿胀。这种水肿反应依赖于 C3a 受体的存在,但与下游补体效应物 C5a 的受体无关。我们的研究结果表明 C3 是炎症过程中 KLKs 的潜在底物之一。鉴于 KLKs 在组织和生物液中的广泛分布,其中也可能表达补体成分,我们认为,通过 C3 加工,组织局部的 KLKs 在先天免疫反应的激活过程中可以发挥外在的补体相关作用。